Cargando…

Choroidal Melanoma: A Mini Review

Choroidal melanoma is a rare malignant tumour, yet it is the most common primary intra-ocular neoplasm and second on the list of top ten most malignant melanoma sites in the body. Clinical presentation can be non-specific and includes photopsia, floaters, progressive visual field loss, and blurry vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliman, Noha, Mamdouh, Diaa, Elkordi, Aisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863301/
https://www.ncbi.nlm.nih.gov/pubmed/36662495
http://dx.doi.org/10.3390/medicines10010011
_version_ 1784875299942432768
author Soliman, Noha
Mamdouh, Diaa
Elkordi, Aisha
author_facet Soliman, Noha
Mamdouh, Diaa
Elkordi, Aisha
author_sort Soliman, Noha
collection PubMed
description Choroidal melanoma is a rare malignant tumour, yet it is the most common primary intra-ocular neoplasm and second on the list of top ten most malignant melanoma sites in the body. Clinical presentation can be non-specific and includes photopsia, floaters, progressive visual field loss, and blurry vision. The tumour is quite often diagnosed clinically during fundus examination; however, the most valued diagnostic tests are A- and B-scan ultrasonography (US). Several factors affect prognosis, including the patient’s age, tumour size, histological features, and presence of metastases. Still, with primary treatment and tight surveillance, around 50% of choroidal melanoma patients metastasise.
format Online
Article
Text
id pubmed-9863301
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98633012023-01-22 Choroidal Melanoma: A Mini Review Soliman, Noha Mamdouh, Diaa Elkordi, Aisha Medicines (Basel) Review Choroidal melanoma is a rare malignant tumour, yet it is the most common primary intra-ocular neoplasm and second on the list of top ten most malignant melanoma sites in the body. Clinical presentation can be non-specific and includes photopsia, floaters, progressive visual field loss, and blurry vision. The tumour is quite often diagnosed clinically during fundus examination; however, the most valued diagnostic tests are A- and B-scan ultrasonography (US). Several factors affect prognosis, including the patient’s age, tumour size, histological features, and presence of metastases. Still, with primary treatment and tight surveillance, around 50% of choroidal melanoma patients metastasise. MDPI 2023-01-05 /pmc/articles/PMC9863301/ /pubmed/36662495 http://dx.doi.org/10.3390/medicines10010011 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Soliman, Noha
Mamdouh, Diaa
Elkordi, Aisha
Choroidal Melanoma: A Mini Review
title Choroidal Melanoma: A Mini Review
title_full Choroidal Melanoma: A Mini Review
title_fullStr Choroidal Melanoma: A Mini Review
title_full_unstemmed Choroidal Melanoma: A Mini Review
title_short Choroidal Melanoma: A Mini Review
title_sort choroidal melanoma: a mini review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863301/
https://www.ncbi.nlm.nih.gov/pubmed/36662495
http://dx.doi.org/10.3390/medicines10010011
work_keys_str_mv AT solimannoha choroidalmelanomaaminireview
AT mamdouhdiaa choroidalmelanomaaminireview
AT elkordiaisha choroidalmelanomaaminireview